Loading...
01/10 00:51
Loading...
AngioDynamics Inc (ANGO) is set to release its earnings performance on 07/15 04:00:00 in Pre-Market trading. Consensus forecasts predict a revenue of 74.26M and an earnings per share (EPS) of -0.13 for the . With Intellectia's exclusive AI algorithms, users can predict whether the earnings will beat or miss expectations before the report drops. Leverage this powerful tool to strategize and position your trades ahead of the earnings release!
The earnings call highlights strong financial performance with revenue growth across multiple segments, improved gross margins, and positive cash flow. The raised guidance for fiscal 2026 and increased adjusted EBITDA outlook further support a positive sentiment. Although some risks were noted, such as competitive pressures and international expansion challenges, the overall outlook and strategic initiatives like the Auryon platform's international traction and positive CPT code changes suggest a favorable stock price movement.
The earnings call revealed strong financial performance, especially in Med Tech, with a 26.1% revenue increase. The company raised guidance for Med Tech, driven by Mechanical Thrombectomy and NanoKnife, indicating confidence in future growth. Despite increased R&D and SG&A expenses, improved operating leverage and profitability were noted. Positive Q&A insights on sales force expansion and clinical trials further support optimism. However, management's reluctance to provide specific metrics for NanoKnife and trial timelines tempers enthusiasm slightly, leading to a positive but not strong positive sentiment.
The earnings call indicates strong financial performance with revenue growth driven by Med Tech and Med Device segments. Positive developments include improved EBITDA and free cash flow, alongside optimistic guidance for Med Tech growth. Although tariffs impacted gross margin, the company is managing these effects. The Q&A reveals confidence in product approvals and growth, particularly for AlphaVac and AngioVac. Despite some ambiguity in management's responses, the overall sentiment is positive with expectations of continued growth, leading to a likely stock price increase of 2% to 8% over the next two weeks.
AngioDynamics Inc (ANGO) is scheduled to release its FY2025Q4 earnings report onJul 15, 2025, Pre-Market(approximately 4:00 PM ET). This timing allows investors to react during after-hours trading, with a conference call typically following shortly after.
Analysts' consensus predicts 74.26M in revenue and an EPS of -0.13 for AngioDynamics Inc's FY2025Q4.
Intellectia's exclusive AI algorithms forecast a forAngioDynamics Inc's FY2025Q4 earnings, with a prediction date of Jul 15, 2025. AngioDynamics Inc
Leverage Intellectia's AI forecast to position trades ahead of theJul 15, 2025 release—consider calls for a beat scenario or protective puts for misses. Focus on pre-market volatility, and use the scenario probabilities to build strategies around revenue and guidance updates.
Intellectia's predictions are backed by rigorous backtesting, showing a high hit rate for Beat and Miss calls compared to traditional analysis. While no forecast is 100% certain, we provide probability-based scenarios (e.g., 50% chance of a *Beat*) and detailed rationales to help you make informed decisions. Combine our insights with your strategy for the best results—it's like having a co-pilot for earnings season! Empowering users to strategize trades before reports drop.
AI Earnings Prediction uses advanced Large Language Models (LLMs) to analyze a wealth of data, including past earnings transcripts, real-time market sentiment, analyst insights, and company news from the last three months. It focuses on key indicators like revenue, EPS, and margins to predict whether a company will *Beat*, *Miss*, or remain Neutral relative to market expectations. Think of it as a super-smart analyst crunching numbers and news 24/7 to give you a trading edge!
Predictions are generated two days before a company’s earnings release (e.g., 5:00 PM ET on Feb 13 for a Feb 15 report) to capture the latest market and company data. They’re updated in real-time if significant news breaks, ensuring you get fresh insights.
Currently, AI Earnings Prediction focuses on companies with market caps above $40 billion, covering major players like SPG, AAPL, MSFT, and NVDA for the 2024-2025 earnings seasons. We prioritize high-impact stocks with robust data to ensure reliable forecasts. Stay tuned as we expand coverage to more companies based on user demand!
Each prediction includes a detailed rationale, key indicator forecasts, and scenario probabilities to guide your trades. For a *Beat*, consider buying call options or shares; for a *Miss*, explore puts or hedging strategies. The prediction card provides actionable suggestions, like specific option strikes or hedging tips, tailored to your risk tolerance. Trade smart and turn insights into profits!
